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ABSTRACT Canine neuroaxonal dystrophy (NAD) is a recessive, degenerative neurological disease of
young adult Rottweiler dogs (Canis lupus familiaris) characterized pathologically by axonal spheroids pri-
marily targeting sensory axon terminals. A genome-wide association study of seven Rottweilers affected
with NAD and 42 controls revealed a significantly associated region on canine chromosome 5 (CFA 5).
Homozygosity within the associated region narrowed the critical interval to a 4.46 Mb haplotype
(CFA5:11.28 Mb – 15.75 Mb; CanFam3.1) that associated with the phenotype. Whole-genome sequencing
of two histopathologically confirmed canine NAD cases and 98 dogs unaffected with NAD revealed a
homozygous missense mutation within the Vacuolar Protein Sorting 11 (VPS11) gene (g.14777774T . C;
p.H835R) that was associated with the phenotype. These findings present the opportunity for an antemor-
tem test for confirming NAD in Rottweilers where the allele frequency was estimated at 2.3%. VPS11
mutations have been associated with a degenerative leukoencephalopathy in humans, and VSP11 should
additionally be included as a candidate gene for unexplained cases of human NAD.
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Neuroaxonal dystrophy (NAD) is a relatively non-specific histopatho-
logical diagnosis for a group of neurodegenerative disorders character-
ized by dystrophic changes of the neuron followed by development of
axonal swellings or spheroids (Revesz et al. 2015). First described by
Cajal, (Cajal 1928) axonal swellings may occur in the central or periph-
eral nervous system and the underlying pathogenesis of the variable
structuredmaterial found in these swellings is often poorly defined. The
dystrophic phenotype may vary depending on age of onset, clinical
manifestations, and specific disorder.
NAD can be divided into three major etiological groups: physiolog-
ical, secondary, and primary. PhysiologicalNAD can be seen commonly
in humans and domesticated species as a component of aging
(Suzuki et al. 1979; Saito 1980; Summers et al. 1995; Borràs et al.
1999; Gavier-Widen et al. 2001; Revesz et al. 2015), and secondary
NAD may be seen focally, or more widely throughout the nervous
system in response to a wide variety of conditions, including trauma,
infection, toxin exposure and metabolic disease such as vitamin E de-
ficiency or organophosphate exposure (Yagishita 1978; Summers et al.
1995; Revesz et al. 2015). Axonal spheroids have also been described
in human patients with amyotrophic lateral sclerosis, Alzheimer’s,
Parkinson’s disease and hereditary spastic paraparesis. Primary
NAD is generally associated with a group of genetically heteroge-
neous, inherited neurodegenerative diseases where the presence of
neuroaxonal dystrophy is a major pathological component of the
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disease. In human patients, neuroaxonal dystrophic pathology has been
associated to varying degrees with several genetically defined disease
syndromes, most prominently in Infantile Neuroaxonal Dystrophy
(INAD) and Pantothanate Kinase-associated Neurodegeneration asso-
ciated with alterations in the PLA2G6, and PANK2 genes respectively.
Many of the human NAD syndromes are also associated with brain
iron accumulation, including alterations in the PLA2G6, PANK2, FTL,
C19orf12, FA2H, and WDR45 genes (Revesz et al. 2015; Arber et al.
2016). Neuroaxonal dystrophy in humans without iron accumulation is
seen inWilson’s disease andNasu-Hakola disease involving theATP7B
and DAP12/TREM2 genes respectively, and in “neuroaxonal leukoen-
cephalopathy with axonal spheroids” which has no defined genetic
cause to date (Revesz et al. 2015). Primary NAD has been reported
in most domesticated species including dogs (Clark et al. 1982;
Chrisman et al. 1984; Blakemore and Palmer 1985; Evans et al. 1988;
Sacre et al. 1993; Franklin et al. 1995; Bennett and Clarke 1997; Siso
et al. 2001; Nibe et al. 2007; Fyfe et al. 2010; Fyfe et al. 2011; Hahn et al.
2015; Pintus et al. 2016; Degl’Innocenti et al. 2017; Tsuboi et al. 2017),
cats (Woodard et al. 1974; Carmichael et al. 1993; Rodriguez et al. 1996;
Résibois and Poncelet 2004), cattle (Hanshaw et al. 2015), sheep (Cordy
et al. 1967; Nuttall 1988; Harper and Morton 1991; Kessell et al. 2012;
Finnie et al. 2014), pigeons (Barrows et al. 2017), mice (Bouley et al.
2006), and horses (Beech 1984; Blythe et al. 1991; Aleman et al. 2011;
Finno et al. 2013; Finno et al. 2016), where an association with vitamin
E deficiency, along with a genetic susceptibility, has been reported.
In dogs, breed relatedNADhas been reported as fetal onset in Giant
Schnauzer-Beagle mix breed dogs (Fyfe et al. 2010; Fyfe et al. 2011),
juvenile onset inDachshundmix breed dogs (Pintus et al. 2016), Border
collies (Clark et al. 1982), Chihuahuas (Blakemore and Palmer 1985;
Degl’Innocenti et al. 2017), Jack Russell Terriers (Sacre et al. 1993),
Papillons (Franklin et al. 1995; Nibe et al. 2007; Tsuboi et al. 2017),
SpanishWater Dogs (Hahn et al. 2015), and young adult or adult onset
in Rottweilers (Cork et al. 1983; Chrisman et al. 1984; Evans et al. 1988;
Bennett and Clarke 1997; Siso et al. 2001) and English Cocker Spaniels
(McLellan et al. 2003). NAD in Cocker Spaniels is accompanied by
retinal degeneration and is associated with vitamin E deficiency
(McLellan et al. 2003). Specific genetic mutations associated with the
PLA2G6, TECPR2 and MFN2 genes have been identified in the Papil-
lon, Spanish Water Dog and Schnauzer-Beagle cross dogs respectively
(Fyfe et al. 2011; Hahn et al. 2015; Tsuboi et al. 2017).
Rottweiler NAD was first reported in the early 1980s and is char-
acterized by a young adult age of onset with mild progression of clinical
signs, typically includingpostural deficits, ataxia, hypermetria, intention
tremor and nystagmus (Cork et al. 1983; Chrisman et al. 1984). Clinical
signs reflect the predominantly sensory topographical distribution of
pathology within the central nervous system (CNS) consisting of mild
cerebellar atrophy, large numbers of axonal spheroids, and demyelin-
ation of axons in the vestibular nucleus, lateral and medial geniculate
nuclei, sensory nucleus of the trigeminal nerve, gracilis and cuneate
nuclei, and in the spinal cord dorsal horn (Cork et al. 1983; Chrisman
et al. 1984). Based on a small pedigree, it was hypothesized to be an
autosomal recessive disorder (Cork et al. 1983).
Defining underlying genetic mechanisms for breed related neuro-
axonal dystrophies in dogs has the potential to provide biological insight
and potential translational models for the heterogeneous disease phe-
notypes seen in human patients (Shearin andOstrander 2010; Hytönen
and Lohi 2016). A genome-wide association was therefore performed
with samples from the original four reported Rottweiler cases (Cork
et al. 1983; Chrisman et al. 1984) and three additional cases, together
with whole-genome sequencing of selected cases to identify candidate
genes for NAD in Rottweilers.
MATERIALS AND METHODS
Canine Samples
Buccal swabsorbloodsampleswere collected fromprivatelyowneddogs
through theWilliamR.PritchardVeterinaryMedicalTeachingHospital
at UC Davis. Collection of canine blood samples was approved by the
University of California, Davis Animal Care and Use Committee
(protocol #16892). Additional Rottweiler DNA samples were pro-
vided by the University of Minnesota and the University of Bern,
Switzerland. These studies were approved according to the national
guidelines for animal welfare by the Institutional Animal Care and
UseCommittees (IACUC) of theUniversity ofMinnesota, and by the
Cantonal Committee for Animal Experiments (Canton of Bern;
permits 23/10, 48/13 and 75/16) for the University of Bern. Owners
specified the breed of each dog. Genomic DNA was extracted using
the Qiagen kit (QIAGEN, Valencia, CA). Neurological phenotypes
were determined by a veterinarian and confirmed postmortem via
necropsy when available.
Genome-wide SNP Genotyping
Genome-wide SNP genotyping was performed on seven cases and
42 controls, using the Illumina CanineHD 220k BeadChip (Illumina,
San Diego, CA, USA). All samples had a genotyping rate of $ 90%.
62,193 SNPs were excluded due to a minor allele frequency# 5% and
7,421 SNPs were excluded due to a high genotype failure rate ($ 10%),
leaving 151,799 SNPs after quality control. A Chi-square analysis and a
genomic inflation factor (l) was calculated with PLINK (Purcell et al.
2007). Homozygosity throughout the associated interval was analyzed
by visual inspection assisted by color-coding homozygous genotypes in
Excel. Homozygosity in the affected dogs, that passed the Bonferroni
threshold (P # 3.29·1027), was used to narrow down the regions of
association and was visualized using Haploview (Barrett et al. 2005;
Barrett 2009; Clarke et al. 2011). Figures were made in R using the
ggplot2 package (Wickham 2009).
Whole-Genome Sequencing
Whole-genome sequencing was performed as described on 100 canine
genomes, (Brown et al. 2017) with two histopathologically con-
firmed Rottweiler cases and 98 dogs unaffected with NAD, across
25 different breeds, including two Rottweilers. Sequencing was
performed on the Illumina HiSeq 2000 using 100bp paired-end
reads with approximately 8.7x coverage per sample. The reads were
aligned to the canine reference genome (CanFam3.1) (Lindblad-Toh
et al. 2005). Local realignment and variant calls were performed using
the Genome Analysis Tool Kit (GATK version 2.5-2gf57256b)
pipeline (McKenna et al. 2010). Biological consequences of variants
were predicted using Ensembl’s Variant Effect Predictor (VEP),
PolyPhen-2 (v2.2.2r398), and SIFT (Adzhubei et al. 2010; Sievers
et al. 2011; Sim et al. 2012; Adzhubei et al. 2013; McLaren et al.
2016;).
Genotyping by Sanger Sequencing
Primers were designed using Primer3 (Rozen and Skaletsky 2000) to
validate the putative functional mutation uncovered in VPS11 (F:
CTGCAGGTCCCTGTCCTAAG;R: TGTACCTGGCTCTTGGCTCT).
PCR products were sequenced using the Big Dye termination kit on an
ABI 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).
Sequences were evaluated using Chromas (Technelysium, South Bris-
bane, QLD, Australia). Sequences were aligned to CanFam3.1 using
BLAT (UCSC Genome Browser). Allele frequency was calculated
excluding the seven affected cases.
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RNA Extraction and cDNA Sequencing
RNA was isolated from liver using Qiagen QIAamp Blood Mini Kit
tissue protocols (QIAGEN,Valencia,CA). RNAwas reverse transcribed
into cDNA using Qiagen QuantiTect Reverse Transcription Kit. Ubiq-
uitously expressed VPS11 (F: TGGTCCAAAAACTGCAGAAA; R:
CTCAAAGCAGTGTTGGTGGA) and the housekeeping gene RPS5
(Brinkhof et al. 2006) cDNAwere PCR amplified from liver tissue from
two affected Rottweilers, one Gordon Setter, and one mixed breed dog.
RPS5 was amplified in liver to ensure equivalent amounts of cDNA
were produced. The PCR products were sequenced on an ABI 3500Ge-
netic Analyzer and analyzed using Chromas (Technelysium, South
Brisbane, QLD, Australia). The sequences were aligned to Can
Fam3.1 using BLAT (UCSCGenome Browser) to confirm the missense
mutation in the cDNA of VPS11.
Data Availability
The SNP genotyping data can be found in files Supplemental 1 (File S1),
and Supplemental 2 (File S2). Whole-genome sequencing files reported
in this paper can be found in the NCBI Sequence Read Archive (SRA
Bioproject no. PRJNA377155). Sequences from four Pugs were made
available in 2012 by TGEN (https://www.tgen.org/patients/canine/).
Supplemental material available at Figshare: https://doi.org/10.25387/
g3.6214010.
RESULTS
Case Definition
DNA samples were available from the four original NAD affected
Rottweilers from Cork et al. (Cork et al. 1983) and three additional cases.
One case was evaluated at the Veterinary Medical Teaching Hospital
VMTH (University of California, Davis) with neurologic deficits and
histopathological findings at necropsy consistent with previously report-
ed cases. Blood samples from two additional dogs were submitted by
their respective owners. Both dogs were presented to veterinarians with a
history and clinical signs consistent with NAD and were noted to be
“clumsy” as puppies. One dog was presented at approximately 1 year of
age with generalized ataxia and hypermetria and absent menace re-
sponses. The second dog was presented for progressive ataxia and hyper-
metria that had been present for several years. Both dogs were alive and
ambulatory at 2 and 5 years of age respectively. The second dog had been
tested previously for mutations associated with two other neurodegen-
erative diseases reported in Rottweilers (leukoencephalomyelopathy
(Minor et al. 2018), laryngeal paralysis-polyneuropathy (Mhlanga-
Mutangadura et al. 2016)) and was negative for both mutations.
Genome-Wide Association Study
To identify loci associated with the NAD phenotype in the Rottweiler
dog, a genome-wide association study was performed, followed by
homozygosity analysis using seven cases affected with NAD and
42healthycontrols. Fourof the sevencasesweredirectly relatedresulting
in a genomic inflation (l) value of 1.52. A chi-square analysis of the
151,799 SNPs, identified preliminary associations on canine chromo-
somes (CFA) 4, 5, 12, 14, 16, 19, and 37 (Figure 1A). The lowest P value
was on CFA 5 (P = 1·10214) and 26 SNPs in this region were more
associated than on the next highest chromosomal location. Since this
disease is uncommon and pedigree analysis was consistent with a re-
cessive mode of inheritance, a homozygosity analysis was performed in
the cases. To identify regions of homozygosity in the cases, P values
from markers with an allele frequency of 1 in the cases were plotted.
There were 45markers thatmet the Bonferroni correction (P# 1·1024),
and all but one (CFA 34; P = 3.71·1025) were on CFA 5, making it the
only statistically significant region of association that met the allele
frequency criteria (Figure 1A-C). Homozygosity throughout the as-
sociated interval was used to narrow down the region of interest to
4.46 Mb (Chr5:11,282,754-15,754,443; CanFam3.1).
Figure 1 GWAS for Rottweiler NAD. A) Manhattan plot for the NAD
GWAS showing the –log10 of the raw P values (Y axis) for each gen-
otyped SNP by chromosome (X axis). Genomic inflation (l) was 1.52. B)
SNPs with an allele frequency of 100% in cases were plotted; with the
–log10 of the raw P values (Y axis) for each SNP by chromosome
(X axis). C) Plot of the –log10 of the raw P values (Y axis) for each
SNP on canine chromosome 5 (CFA 5). D) Haplotypes observed in
the seven cases, showing homozygosity throughout the associated
region. Runs of homozygosity are marked by the gray horizontal bars.
The critical interval is marked by the shared homozygous haplotype in
between the black bracket (CFA5: 11.29 Mb – 15.75 Mb).
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Whole-Genome Sequencing
Variants within the critical interval, identified in the GWAS, were
analyzed for association using 98 dogs unaffected with NAD and two
Rottweilers histopathologically confirmed to have NAD. Within the
critical interval, there were 73 genes, and 31,749 SNPs and 17,421 indels
were identified. 164 SNP variants and 15 indels segregated with the
phenotypewerewithin the region identifiedonCFA5.Only a singleSNP
was found to be protein coding (CFA 5:14,777,774) among the segre-
gating variants. The remaining variants were 39 UTR (n = 4), down-
stream (n = 23), intergenic (n = 74), intronic (n = 56), a non-coding
transcript (n = 5), or upstream variants (n = 16).
VPS11 Non-Synonymous Variant
Anon-synonymous variantwas identifiedonCFA5 (g.14777774T.C;
CanFam3.1) in the Vacuolar Protein Sorting 11 (VPS11) gene. The
variant leads to an amino acid change (p.H835R) in the Zinc RING
finger domain of the protein (Figure 2B), which is ultimately predicted
to be deleterious (VEP: moderate; PolyPhen-2: 0.999; SIFT: 0).
The cDNA of VPS11 was sequenced from liver from two NAD af-
fected Rottweilers, one Gordon Setter, and one mixed breed dog,
(Figure 2.A) to confirm the presence of the mutation in the mRNA
(VPS11c.2504A . G). VPS11 is highly conserved across species
(Table S1), with humans and dogs having 98.2% conservation at the
amino acid level (Figure 2.B).
VPS11 Variant Genotyping
440 dogs, consisting of 288 Rottweilers, and 152 dogs from 19 other
breeds, were genotyped for the VPS11 mutation (Table 1). Of the
288 Rottweilers, 13 were identified as heterozygous for the mutation,
seven were homozygous for the mutation (cases as described above),
and the remaining 268 Rottweilers, along with the 152 other dogs, were
all homozygous for the reference allele. Of the Rottweilers genotyped,
211 were from the United States of America (204 wild type, three
heterozygous, and seven homozygous mutants); 75 were from Europe
(65 wild type and 10 heterozygous). The frequency of the mutant allele
in this population is estimated to be 2.3%.
DISCUSSION
Seven Rottweilers that presented with clinical signs consistent with the
NAD phenotype were homozygous for a non-synonymous mutation
within the RING-finger domain of the Vacuolar Protein Sorting
11 (VPS11) gene (Figure 2). In order to overcome significant population
stratification based on relatedness of the affected cases, a genome-wide
association followed by homozygosity mapping was used. This type of
approach has been used successfully in the past to identify breed spe-
cific Mendelian recessive diseases in dogs (Drögemüller et al. 2009;
Kropatsch et al. 2010; Forman et al. 2016).
Sorting and degradation of internalized cell surface proteins and
lipids in eukaryotic cells is controlled through the “endocytic network”
(Balderhaar and Ungermann 2013; Spang 2016), such that surface
proteins may progress through early and late endosomes before they
are degraded in lysosomes, ormay be sorted and recycled. Disposal and
recycling of cytoplasmic components is similarly achieved through the
autophagosome-lysosome pathway during autophagy (Levine and
Klionsky 2004; Nixon 2013) (Figure 3).
TwoVPSclassCcomplexes,CORVETandHOPS, eachcomposedof
multipledifferentVPSproteinsareessential for controlof themembrane
fusion machinery and trafficking of material through these endosome-
lysosome organelles. CORVET and HOPS act as tethers, in coordina-
tion with other key proteins such as RAB5 and RAB7, and bring
Figure 2 VPS11 sequence electrophe-
rograms and amino acid alignment
with human VPS11. A) Electrophero-
gram of the missense mutation ()
(g.14777774T . C) within the cDNA
of VPS11. B) Amino acid sequence
alignment of human and dog (wild
type and mutant) Vacuolar Protein
Sorting 11 showing 98.2% amino acid
conservation across species. The Zinc
RING finger domain is in green with
the location of the missense variant
denoted by an asterisk below the
aligned sequence (specific amino acid
is highlighted in red). Non-conserved
amino acids are in blue, and known
disease causing mutations in human
patients are in red.
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appropriately targeted vesicles into close proximity with the target
membrane (Richardson et al. 2004; Balderhaar and Ungermann
2013; Perini et al. 2014; van der Kant et al. 2015; Spang 2016). Both
CORVET (class C core vacuole/endosome tethering complex) and
HOPS (homotypic fusion and protein transport) contain a four-
subunit core consisting of VPS11 (PEP5), VPS16, VPS18 (PEP3),
and VPS33, which are conserved across yeast, insects, plants, and
mammals (Nickerson et al. 2009). VPS11 has been shown to have a
key role in determining selective binding to either early or late endo-
somes, and as an integrator of the complex assembly (Plemel et al.
2011; van der Kant et al. 2015). The RING domain of VPS11 that
harbors the non-synonymous mutation in Rottweiler NAD has been
shown to be important specifically in fusion at the vacuole (lysosome)
in yeast (Plemel et al. 2011).
Mutation of the VPS11 gene in humans is associated with an in-
fantile onset neurological syndrome characterized by hypomyelination
and variable neurological deficits including motor and cognitive im-
pairment, dystonia, ataxia, visual deficits, and seizures (Figure 2.B)
(Edvardson et al. 2015; Hörtnagel et al. 2016; Zhang et al. 2016). His-
topathological characterization has not been done. However, the syn-
drome is classified as a leukoencephalopathy based on MRI (magnetic
resonance imaging) findings, and skin and bone marrow biopsies were
suggestive of a lysosomal storage type disease (Hörtnagel et al. 2016).
Consistent with the known function of VSP11 (Plemel et al. 2011),
in vitro studies of the mutant human protein resulted in disruption
of late endosome/vacuole fusion and the autophagic pathway
(Edvardson et al. 2015; Zhang et al. 2016). Although the Rottweiler
VPS11 mutation is in a similar location to one of the documented
human mutations within the VPS11 RING finger domain (Figure 2.B)
(Edvardson et al. 2015; Zhang et al. 2016), the clinical phenotypes
appear to have distinct differences, most notably the apparent white
matter vs. gray matter distribution of lesions in humans vs. dogs. The
human VPS11 syndrome also appears to be characterized by lysosomal
accumulations compared to axonal spheroids (Hörtnagel et al. 2016),
although detailed histopathological characterization of human CNS
lesions is not available. However, this spectrum of intracellular accu-
mulations of varying types is within the rational consequences of dis-
ruption of the endosome-autophagosome-lysosome system predicted
following VPS11 (CORVET/HOPS) dysfunction. Additionally, species
and site specific differences in pathological phenotype for mutations
within the same gene are well documented across a broad range of
genetic diseases. For example, a variety of clinical and pathological
phenotypes have been reported for alterations within the same genes
that cause some of the neuroaxonal dystrophy syndromes in humans
(Revesz et al. 2015; Arber et al. 2016); PLA2G6 genemutations can give
a spectrum of disease phenotypes as well as classical INAD including
dystonia-parkinsonism syndromes and spastic paraplegia (Gregory
et al. 2008; Ozes et al. 2017). Similarly, alterations in the MFN2 gene
give rise to fetal onset NAD in dogs (Fyfe et al. 2010; Fyfe et al. 2011);
however, human alterations result in peripheral nervous system syn-
dromes (Charcot-Marie-Tooth disease type 2A2 and hereditary motor
and sensory neuropathy type 6A (Del Bo et al. 2008)), while mouse
knockouts and transgenic overexpression and cattle with alteredMFN2
have CNS and PNS neurodegeneration but do not have NAD
(Drögemüller et al. 2011). Protein site-specific effects, species differ-
ences in pathological responses (such as lack of iron accumulation in
canineNAD), and differences in gain or loss of functionmutationsmay
all contribute to the phenotypic heterogeneity.
Despite this heterogeneity within the NAD disease phenotype,
common pathological pathways are implicated in many NAD syn-
dromes, including the primary and secondary diseases. Vitamin E
deficiency has been associated to varying degrees with axonal dystrophy
in both experimental and clinical settings, in several species including
Figure 3 Schematic representation of the endosome-autophago-
some-lysosome pathway. VPS11 is a key constituent of the VPS class
C complexes CORVET (red) and HOPS (blue). Disruption of the
CORVET/HOPS tethering complexes, and subsequently the mem-
brane fusion processes required for appropriate trafficking, would be
consistent with both the lysosomal storage and NAD phenotypes seen
in human and dog disease, secondary to accumulation of membrane
and cytosolic constituents. Blue arrows represent fusion events
mediated by HOPS, red arrows represent fusion events mediated by
CORVET, dashed gray arrows represent pathways of exocytosis and
plain gray lines represent pathways of endocytosis.
n Table 1 VPS11 (g.14777774T > C) MUTATION GENOTYPING
RESULTS
BREED TOTAL
VPS11/
VPS11
VPS11/
vps11
vps11/
vps11
Boston Terrier 2 2 0 0
Boxer 33 33 0 0
Brittany 3 3 0 0
Bulldog 5 5 0 0
Dachshund 1 1 0 0
French Bulldog 3 3 0 0
German Shorthaired
Pointer
4 4 0 0
Golden Retriever 39 39 0 0
Great Dane 2 2 0 0
Irish Setter 1 1 0 0
Labrador Retriever 17 17 0 0
Mixed Breeds 6 6 0 0
Newfoundland 4 4 0 0
Nova Scotia Duck
Tolling Retriever
13 13 0 0
Pug 5 5 0 0
Rottweiler 288 268 13 7
Saluki 2 2 0 0
Weimaraner 5 5 0 0
West Highland White
Terrier
2 2 0 0
Whippet 5 5 0 0
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dogs, rodents, horses and primates (Nelson et al. 1981; Pillai et al. 1994;
McLellan et al. 2003; Finno et al. 2013; Finno et al. 2016). The impor-
tance of the complex relationship between pathways controlling reac-
tive oxygen species (ROS) and autophagy has been well documented
(Underwood et al. 2010; Fang et al. 2017), and the autophagy pathway
is particularly important in the context of the highly metabolic neuron
(Nixon 2013). Previously defined genes associated with NAD in dogs
(PLA2G6, TECPR2 and MFN2) as well as many human NAD related
genes have been proposed as potential modulators of the autophagy
pathway (Fyfe et al. 2011; Hahn et al. 2015; Meyer et al. 2015; Arber
et al. 2016; Tsuboi et al. 2017), and the currently described VPS11 gene
alteration in Rottweiler NAD would be predicted to affect the autopha-
gic, as well as other lysosomal pathways. High conservation of VPS11
between species, the essential role VPS11 plays in the endosomal-auto-
phagy-lysosomal pathways, and the impact of mutations in VPS11
leading to neurodegenerative diseases, provides strong support for
the missense mutation identified in Rottweiler NAD to be causative
for the disease and a potential candidate for unexplained forms of
human NAD. Detailed biological analysis of the Rottweiler VPS11
specific mutation will be needed to fully understand the apparent spe-
cies/mutation differences in disease expression and its potential value as
a translational model.
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